|Articles|December 15, 2002
CTCL Vaccines
Paris - One of the most promising areas of research for treatment of cutaneous T-cell lymphoma is the development of therapeutic vaccines, according to Wolfram Sterry, M.D., who presented an overview of vaccination therapies for treatment of CTCL here at the World Congress of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5














